Medical Genetics Service, Hospital de Clínicas, Porto Alegre, RS, Brazil.
Mol Genet Metab. 2011 Dec;104(4):603-7. doi: 10.1016/j.ymgme.2011.09.017. Epub 2011 Sep 20.
Mucopolysaccharidosis type VI (MPS VI, Maroteaux-Lamy syndrome) is a lysosomal storage disease caused by deficiency of arylsulphatase B. The incidence of MPS VI is very low, usually less than 1 case for every 1,000,000 newborns. In Northeast Brazil we identified in the county of Monte Santo (52,360 inhabitants) thirteen patients with MPS VI. The aim of this work was to identify the mutation(s) present in these patients and analyze intragenic SNPs to define possible haplotypes. The 13 MPS VI patients were found to be homozygous for the p.H178L mutation. All patients have the same haplotype for the intragenic SNPs. Based on current data, the prevalence of MPS VI in this region is estimated as 1:5,000 newborns. These results, together with pedigree analysis, strongly suggest a founder effect accounting for the high frequency of p.H178L mutation in this area. This reinforces the need of a comprehensive community genetics program for this area.
黏多糖贮积症 VI 型(MPS VI,马罗泰克斯-拉米综合征)是一种溶酶体贮积病,由芳基硫酸酯酶 B 缺乏引起。MPS VI 的发病率非常低,通常每 100 万新生儿中不到 1 例。在巴西东北部,我们在蒙特圣多县(52360 名居民)发现了 13 名 MPS VI 患者。本工作的目的是鉴定这些患者存在的突变,并分析内含子 SNPs 以定义可能的单倍型。13 名 MPS VI 患者均为 p.H178L 突变的纯合子。所有患者的内含子 SNPs 具有相同的单倍型。根据目前的数据,该地区 MPS VI 的患病率估计为每 5000 名新生儿中有 1 例。这些结果,加上系谱分析,强烈提示该地区 p.H178L 突变的高频与一个奠基者效应有关。这进一步强调了该地区需要进行全面的社区遗传学计划。